| scholarly article | Q13442814 |
| P2093 | author name string | Yu-Ru Liu | |
| Yi-Fen Lee | |||
| Peng-Nien Yin | |||
| Christopher R Silvers | |||
| P2860 | cites work | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder. | Q40591671 | ||
| Insights from animal models of bladder cancer: recent advances, challenges, and opportunities | Q41339763 | ||
| Decorin regulates endothelial cell-matrix interactions during angiogenesis. | Q41869021 | ||
| Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer | Q42516513 | ||
| Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment | Q45875424 | ||
| In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154. | Q45889330 | ||
| Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer. | Q47327779 | ||
| Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. | Q52089307 | ||
| Intrinsic subtypes and bladder cancer metastasis. | Q55078504 | ||
| Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines. | Q55397522 | ||
| An Anti-oncogenic Role for Decorin | Q61771871 | ||
| Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses | Q73344235 | ||
| Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo | Q74061519 | ||
| Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor | Q82995453 | ||
| Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of nonmalignant cells | Q90796727 | ||
| Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer | Q90872171 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Technologies for deriving primary tumor cells for use in personalized cancer therapy | Q26829581 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study | Q28139358 | ||
| Comprehensive molecular profiling of lung adenocarcinoma | Q28244995 | ||
| Decorin is a biological ligand for the epidermal growth factor receptor | Q28297196 | ||
| Generation of breast cancer stem cells through epithelial-mesenchymal transition | Q29619717 | ||
| CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization | Q30408689 | ||
| Profiling the evolution of human metastatic bladder cancer | Q30435004 | ||
| Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy | Q33572016 | ||
| Current animal models of bladder cancer: Awareness of translatability (Review) | Q33962620 | ||
| Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival | Q34170410 | ||
| Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway | Q34486845 | ||
| Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. | Q34698294 | ||
| Spherical cancer models in tumor biology | Q35023931 | ||
| Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment | Q35150664 | ||
| Transurethral Induction of Mouse Urinary Tract Infection | Q35164172 | ||
| Modelling bladder cancer in mice: opportunities and challenges | Q35285703 | ||
| A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells. | Q35413739 | ||
| Wild type N-ras displays anti-malignant properties, in part by downregulating decorin | Q35539813 | ||
| Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis | Q36004184 | ||
| KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro | Q36095196 | ||
| Radical cystectomy for bladder cancer: the case for early intervention | Q36111220 | ||
| The biology and function of exosomes in cancer | Q36737945 | ||
| Experimental models for therapeutic studies of transitional cell carcinoma. | Q36985572 | ||
| Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer | Q37269014 | ||
| An essential role for decorin in bladder cancer invasiveness | Q37557168 | ||
| Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology | Q37612632 | ||
| Cell plasticity and heterogeneity in cancer. | Q38065648 | ||
| A pathology atlas of the human cancer transcriptome | Q38619228 | ||
| Characteristics and Significance of the Pre-metastatic Niche | Q38795190 | ||
| Active Wnt proteins are secreted on exosomes. | Q39277713 | ||
| Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro | Q39656364 | ||
| Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells | Q39978268 | ||
| Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy. | Q40366972 | ||
| P4510 | describes a project that uses | ggplot2 | Q326489 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metastatic potential | Q122615215 |
| P304 | page(s) | 7425 | |
| P577 | publication date | 2019-05-15 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Enhanced metastatic potential in the MB49 urothelial carcinoma model | |
| P478 | volume | 9 |
| Q91789503 | HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer | cites work | P2860 |
Search more.